Dysmenorrhea

• CLINICAL_TRIALS withdrawal · 2025-11-25
  Clinical Trial Update: Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study [Phase 2]

  The Phase 2 FEAT trial investigating endometrial ablation with an implantable progesterone device has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2024-07-23
  Clinical Trial Update: Chinese Herbal Medicine for Gynecologic Patients [Phase 2]

  This Phase 2 trial investigating Chinese Herbal Medicine for dysmenorrhea in gynecologic patients has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2016-02-17
  Clinical Trial Update: To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea [Phase 3]

  The sponsor has withdrawn a Phase 3 trial evaluating YAZ for the treatment of Dysmenorrhea.

• CLINICAL_TRIALS withdrawal · 2013-08-29
  Clinical Trial Update: Continuous Use of the Contraceptive Patch and the Personal Economic Impact. [NA]

  Clinical trial investigating continuous use of the contraceptive patch and its personal economic impact has been withdrawn. No results are a…

• EMA withdrawal · 2010-02-03
  EMA Withdrawn: Bextra (valdecoxib) — Pharmacia - Pfizer EEIG

  The EMA indicates Bextra (valdecoxib) has been withdrawn from the market by Pharmacia - Pfizer EEIG.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.